What is Better U?
Better U operates at the intersection of digital health and psychiatric innovation, providing a structured framework for at-home ketamine treatment and psychedelic therapy. By leveraging virtual consultations and evidence-based clinical protocols, the company addresses critical gaps in the treatment of depression, anxiety, OCD, and PTSD. Their platform serves as a modern alternative to traditional pharmaceutical interventions, integrating personalized coaching with clinical oversight to foster sustainable mental health outcomes. As the demand for alternative psychiatric care grows, Better U is establishing itself as a key player in the burgeoning psychedelic medicine sector, focusing on accessibility and patient-centric care models.
How much funding has Better U raised?
Better U has raised a total of $1.2M across 1 funding round:
Other Financing Round
$1.2M
Other Financing Round (2024): $1.2M, investors not publicly disclosed
Key Investors in Better U
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Better U?
With this major strategic investment, Better U is poised to accelerate its market penetration and enhance its clinical infrastructure. The company is expected to prioritize the expansion of its virtual care platform, potentially increasing its capacity for patient intake and refining its integration coaching services. Future growth will likely involve navigating the evolving regulatory landscape for psychedelic medicine while scaling its team of clinicians to meet rising demand. By focusing on operational efficiency and evidence-based outcomes, Better U aims to solidify its leadership in the mental health technology space, setting the stage for long-term institutional growth and broader adoption of its therapeutic modalities.
See full Better U company page
